Annual CFF
$567.00 K
+$567.00 K+100.00%
01 December 2023
Summary:
Artelo Biosciences annual cash flow from financing activities is currently $567.00 thousand, with the most recent change of +$567.00 thousand (+100.00%) on 01 December 2023. During the last 3 years, it has fallen by -$17.69 million (-96.90%). ARTL annual CFF is now -96.90% below its all-time high of $18.26 million, reached on 01 December 2021.ARTL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$0.00
$0.000.00%
01 September 2024
Summary:
Artelo Biosciences quarterly cash flow from financing activities is currently $0.00, unchanged on 01 September 2024. Over the past year, it has dropped by -$32.00 thousand (-100.00%). ARTL quarterly CFF is now -100.00% below its all-time high of $18.26 million, reached on 30 November 2021.ARTL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$87.00 K
-$535.00 K-86.01%
01 September 2024
Summary:
Artelo Biosciences TTM cash flow from financing activities is currently $87.00 thousand, with the most recent change of -$535.00 thousand (-86.01%) on 01 September 2024. Over the past year, it has dropped by -$480.00 thousand (-84.66%). ARTL TTM CFF is now -99.66% below its all-time high of $25.80 million, reached on 30 November 2021.ARTL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARTL Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -100.0% | -84.7% |
| 3 y3 years | -96.9% | - | - |
| 5 y5 years | -93.2% | +100.0% | -98.9% |
ARTL Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -96.9% | -100.0% | +100.0% | -99.6% | ||
| 5 y | 5 years | -96.9% | -100.0% | +100.0% | -99.7% | ||
| alltime | all time | -96.9% | -100.0% | +100.0% | -99.7% |
Artelo Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $87.00 K(-86.0%) |
| June 2024 | - | $0.00(-100.0%) | $622.00 K(0.0%) |
| Mar 2024 | - | $55.00 K(+71.9%) | $622.00 K(+9.7%) |
| Dec 2023 | $567.00 K(>+9900.0%) | $32.00 K(-94.0%) | $567.00 K(-15.2%) |
| Sept 2023 | - | $535.00 K(>+9900.0%) | $669.00 K(+399.3%) |
| June 2023 | - | $0.00(0.0%) | $134.00 K(>+9900.0%) |
| Mar 2023 | - | $0.00(-100.0%) | $0.00(0.0%) |
| Dec 2022 | $0.00(-100.0%) | $134.00 K(>+9900.0%) | $0.00(-100.0%) |
| Sept 2022 | - | $0.00(-100.0%) | $18.13 M(-8.1%) |
| June 2022 | - | -$134.00 K(-100.7%) | $19.72 M(-23.5%) |
| Dec 2021 | $18.26 M(+29.4%) | - | - |
| Nov 2021 | - | $18.26 M(+1043.7%) | $25.80 M(+82.8%) |
| Aug 2021 | $14.11 M(+612.4%) | $1.60 M(+158.6%) | $14.11 M(-0.8%) |
| May 2021 | - | $617.50 K(-88.4%) | $14.23 M(+2.4%) |
| Feb 2021 | - | $5.32 M(-19.2%) | $13.89 M(+62.0%) |
| Nov 2020 | - | $6.58 M(+284.7%) | $8.57 M(+332.8%) |
| Aug 2020 | $1.98 M(-76.4%) | $1.71 M(+505.0%) | $1.98 M(-71.6%) |
| May 2020 | - | $282.70 K(>+9900.0%) | $6.97 M(-1.9%) |
| Feb 2020 | - | $2100.00(-115.0%) | $7.10 M(-13.2%) |
| Nov 2019 | - | -$14.00 K(-100.2%) | $8.19 M(-2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Aug 2019 | $8.38 M(+503.3%) | $6.70 M(+1498.5%) | $8.38 M(+279.8%) |
| May 2019 | - | $419.00 K(-61.4%) | $2.21 M(+7.3%) |
| Feb 2019 | - | $1.09 M(+525.0%) | $2.06 M(+32.6%) |
| Nov 2018 | - | $173.90 K(-66.9%) | $1.55 M(+11.7%) |
| Aug 2018 | $1.39 M(+76.8%) | $525.80 K(+94.9%) | $1.39 M(+1.7%) |
| May 2018 | - | $269.80 K(-53.6%) | $1.36 M(+1.2%) |
| Feb 2018 | - | $581.40 K(+5000.0%) | $1.35 M(+71.9%) |
| Nov 2017 | - | $11.40 K(-97.7%) | $784.30 K(-0.1%) |
| Aug 2017 | $785.30 K(>+9900.0%) | $502.20 K(+98.0%) | $785.30 K(+177.4%) |
| May 2017 | - | $253.60 K(+1383.0%) | $283.10 K(+747.6%) |
| Feb 2017 | - | $17.10 K(+37.9%) | $33.40 K(+104.9%) |
| Nov 2016 | - | $12.40 K(>+9900.0%) | $16.30 K(+219.6%) |
| Aug 2016 | $5000.00(-68.4%) | $0.00(-100.0%) | $5100.00(-58.9%) |
| May 2016 | - | $3900.00(>+9900.0%) | $12.40 K(-27.1%) |
| Feb 2016 | - | $0.00(-100.0%) | $17.00 K(0.0%) |
| Nov 2015 | - | $1200.00(-83.6%) | $17.00 K(+7.6%) |
| Aug 2015 | $15.80 K(-47.3%) | $7300.00(-14.1%) | $15.80 K(+85.9%) |
| May 2015 | - | $8500.00(>+9900.0%) | $8500.00(>+9900.0%) |
| Feb 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2014 | - | $0.00 | $0.00 |
| Aug 2014 | $30.00 K | - | - |
FAQ
- What is Artelo Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Artelo Biosciences?
- What is Artelo Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Artelo Biosciences?
- What is Artelo Biosciences quarterly CFF year-on-year change?
- What is Artelo Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Artelo Biosciences?
- What is Artelo Biosciences TTM CFF year-on-year change?
What is Artelo Biosciences annual cash flow from financing activities?
The current annual CFF of ARTL is $567.00 K
What is the all time high annual CFF for Artelo Biosciences?
Artelo Biosciences all-time high annual cash flow from financing activities is $18.26 M
What is Artelo Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of ARTL is $0.00
What is the all time high quarterly CFF for Artelo Biosciences?
Artelo Biosciences all-time high quarterly cash flow from financing activities is $18.26 M
What is Artelo Biosciences quarterly CFF year-on-year change?
Over the past year, ARTL quarterly cash flow from financing activities has changed by -$32.00 K (-100.00%)
What is Artelo Biosciences TTM cash flow from financing activities?
The current TTM CFF of ARTL is $87.00 K
What is the all time high TTM CFF for Artelo Biosciences?
Artelo Biosciences all-time high TTM cash flow from financing activities is $25.80 M
What is Artelo Biosciences TTM CFF year-on-year change?
Over the past year, ARTL TTM cash flow from financing activities has changed by -$480.00 K (-84.66%)